Fedratinib hydrochloride hydrate
Fedratinib hydrochloride hydrate is an orally bioavailable, selective, and ATP-competitive small molecule inhibitor of JAK2. It is widely used in preclinical research to investigate myeloproliferative neoplasms, demonstrating activity in both cellular assays and animal models of disease.
Product Specifications
CAS Number
1374744-69-0
Product Name Alternative
Field of Research
Cardiovascular Research, Cell Biology, Epigenetics & Chromatin, Pharmacology & Drug Discovery, Signal Transduction, Stem Cell & Developmental Biology
Purity
98.96% (May vary between batches)
Solubility
DMSO:120 mg/mL (194.93 mM) ;10% DMSO+40% PEG300+5% Tween 80+45% Saline:4 mg/mL (6.5 mM) ; H2O:97 mg/mL (157.57 mM)
Smiles
O.Cl.Cl.Cc1cnc (Nc2ccc (OCCN3CCCC3) cc2) nc1Nc1cccc (c1) S (=O) (=O) NC (C) (C) C
Molecular Formula
C27H40Cl2N6O4S
Molecular Weight
615.61
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
Human Zinc finger and BTB domain-containing protein 3 (ZBTB3) ELISA Kit
Human Zinc finger and BTB domain-containing protein 3 (ZBTB3) ELISA Kit
Human Monoclonal SARS-CoV-2 Omicron (XBB.1) Spike Antibody (D008) - Chimeric, (RBD)
